ACB vs. CRON, THCX, TLRY, GUD, WEED, OGI, CPH, FIRE, EPI, and ICC
Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Cronos Group (CRON), Hydropothecary (THCX), Tilray Brands (TLRY), Knight Therapeutics (GUD), Canopy Growth (WEED), Organigram (OGI), Cipher Pharmaceuticals (CPH), Supreme Cannabis (FIRE), ESSA Pharma (EPI), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Aurora Cannabis vs. Its Competitors
Aurora Cannabis (TSE:ACB) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.
Aurora Cannabis currently has a consensus target price of C$8.75, suggesting a potential upside of 32.98%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, equities analysts plainly believe Aurora Cannabis is more favorable than Cronos Group.
Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.
13.4% of Aurora Cannabis shares are held by institutional investors. Comparatively, 16.0% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Cronos Group had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 2 mentions for Cronos Group and 0 mentions for Aurora Cannabis. Cronos Group's average media sentiment score of 0.46 beat Aurora Cannabis' score of -0.20 indicating that Cronos Group is being referred to more favorably in the news media.
Aurora Cannabis has a beta of 2.71, suggesting that its stock price is 171% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.
Aurora Cannabis has a net margin of -22.55% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -4.40% beat Aurora Cannabis' return on equity.
Summary
Aurora Cannabis and Cronos Group tied by winning 8 of the 16 factors compared between the two stocks.
Get Aurora Cannabis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aurora Cannabis Competitors List
Related Companies and Tools
This page (TSE:ACB) was last updated on 8/20/2025 by MarketBeat.com Staff
MarketBeat All Access